Scutellarin alleviates renal ischemia–reperfusion injury by inhibiting the MAPK pathway and pro‐inflammatory macrophage polarization
The FASEB Journal · 15.07.2024 · 38 (13)
DOI: 10.1096/fj.202302243r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 03.07.2024. Verfasst von Ge Deng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Kidney Transplantation, Hospital of Nephropathy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Apigenin, Glucuronates, Macrophages, MAP Kinase Signaling System. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China (NSFC), Natural Science Foundation of Shaanxi Province (Shaanxi Natural Science Foundation).
Abstract (Originalsprache)
Renal ischemia–reperfusion injury (IRI) is an integral process in renal transplantation, which results in compromised graft survival. Macrophages play an important role in both the early inflammatory period and late fibrotic period in response to IRI. In this study, we investigated whether scutellarin (SCU) could protect against renal IRI by regulating macrophage polarization. Mice were given SCU (5–50 mg/kg) by gavage 1 h earlier, followed by a unilateral renal IRI. Renal function and pathological injury were assessed 24 h after reperfusion. The results showed that administration of 50 mg/kg SCU significantly improved renal function and renal pathology in IRI mice. In addition, SCU alleviated IRI‐induced apoptosis. Meanwhile, it reduced macrophage infiltration and inhibited pro‐inflammatory macrophage polarization. Moreover, in RAW 264.7 cells and primary bone marrow‐derived macrophages (BMDMs) exposed to SCU, we found that 150 μM SCU inhibited these cells to polarize to an inflammatory phenotype induced by lipopolysaccharide (LPS) and interferon‐γ (IFN‐γ). However, SCU has no influence on anti‐inflammatory macrophage polarization in vivo and in vitro induced by in interleukin‐4 (IL‐4). Finally, we explored the effect of SCU on the activation of the mitogen‐activated protein kinase (MAPK) pathway both in vivo and in vitro. We found that SCU suppressed the activation of the MAPK pathway, including the extracellular signal‐regulated kinase (ERK), Jun N‐terminal kinase (JNK), and p38. Our results demonstrated that SCU protects the kidney against IRI by inhibiting macrophage infiltration and polarization toward pro‐inflammatory phenotype via the MAPK pathway, suggesting that SCU may be therapeutically important in treatment of IRI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Kidney Transplantation, Hospital of Nephropathy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Burn and Plastic Surgery, Shaanxi Provincial People's Hospital, Xi'an, China.
ORCID-Profile: Ge Deng, Bingxuan Zheng, Meng Dou, Yang Gao, Xingzhe Zhang, Zejiaxin Niu, Tian Wei, Feng Han, Chenguang Ding, Puxun Tian
Förderung
- National Natural Science Foundation of China (NSFC)
- Natural Science Foundation of Shaanxi Province (Shaanxi Natural Science Foundation)
Zitieren
APA
Deng, G., Zheng, B., Dou, M., Gao, Y., Zhang, X., Niu, Z., Wei, T., Han, F., Ding, C., & Tian, P. (2024). Scutellarin alleviates renal ischemia–reperfusion injury by inhibiting the MAPK pathway and pro‐inflammatory macrophage polarization. The FASEB Journal, 38(13). https://doi.org/10.1096/fj.202302243r
Vancouver
Deng G, Zheng B, Dou M, Gao Y, Zhang X, Niu Z, et al. Scutellarin alleviates renal ischemia–reperfusion injury by inhibiting the MAPK pathway and pro‐inflammatory macrophage polarization. The FASEB Journal. 2024;38(13). doi:10.1096/fj.202302243r
BibTeX
@article{Deng2024,
author = {Deng, Ge and Zheng, Bingxuan and Dou, Meng and Gao, Yang and Zhang, Xingzhe and Niu, Zejiaxin and Wei, Tian and Han, Feng and Ding, Chenguang and Tian, Puxun},
title = {Scutellarin alleviates renal ischemia–reperfusion injury by inhibiting the MAPK pathway and pro‐inflammatory macrophage polarization},
journal = {The FASEB Journal},
year = {2024},
volume = {38},
number = {13},
doi = {10.1096/fj.202302243r}
}
EUVIMED